It is clear that virtual care is here to stay, but it is not the availability of technology that will govern how care is delivered. Rather, patients' preferences, along with their underlying social needs, will determine which care delivery strategy providers need to use to ensure optimal outcomes.
Founded in 2020, Scorpion is agnostic about the potential therapies and targets it will explore with what it describes as its drug-hunting engine. But the company is hoping to unveil its first drug candidate this year.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The hospital and digital health company have expanded their partnership focused on personalizing treatment for those who suffer from chronic pain. This will give Fern Health access to millions of de-identified patient records.
The company was the site of a large outbreak of the disease linked to a February management meeting. Employees who contracted and recovered from Covid-19, and those who had contact with them, are eligible to provide samples, which will be used to generate de-identified data.
The Microsoft co-founder and billionaire philanthropist's choices for the healthcare innovations that have the potential to change the world range from personalized cancer vaccines to voice assistants.
Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Massachusetts General Hospital is working with Jana Care to conduct a study on the company's heart failure management mobile app, called Heart Habits.
Massachusetts General Hospital and Memotext using digital health technology in an attempt to improve medication adherence in children with ADHD.
To avoid patient confusion and frustration, Mass General has launched an interactive map of its campus.
An orthopedic surgeon warns counterparts in Europe to learn from the opioid epidemic in the U.S., while a Mass General researcher looks for better ways to manage pain.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The new InLight EHR, based on technology licensed from Massachusetts General Hospital, can trace its roots back to informatics pioneers Dr. Octo Barnett and Dr. Larry Weed.
Slavin joins the likes of former Massachusetts Gov. Deval Patrick and Brendan O’Grady, CEO of Teva North American Generics, on the board.
"If you have a $1.5 billion research operation, how can you most effectively capitalize on the intellectual capital that comes out of all that research?" Partners Healthcare CFO Peter Markell said at the JPM conference. One answer: Early stage venture funding.
AZTherapeutics approach is a two-pronged approach to treating Alzheimer's - slowing down plaque buildup and inhibiting the neuroinflammatory response.
MicroMedicine, a new MGH spinout, is raising $35 million for its microfluidics technology. It's led by the founders of Verinata Health, which was acquired by Illumina in 2013 for $350 million.